Hubei Goto Biopharm Co.,Ltd. (SHE:300966)
China · Delayed Price · Currency is CNY 20.93
+0.23 (1.11%)
Mar 30, 2026, 3:04 PM CST
Hubei Goto Biopharm Market Cap
Hubei Goto Biopharm has a market cap or net worth of 2.41 billion as of March 30, 2026. Its market cap has increased by 24.74% in one year.
Market Cap
2.41B
Enterprise Value
3.67B
Revenue
626.28M
Ranking
n/a
PE Ratio
n/a
Stock Price
20.93
Market Cap Chart
Since April 9, 2021, Hubei Goto Biopharm's market cap has decreased from 6.57B to 2.41B, a decrease of -63.34%. That is a compound annual growth rate of -18.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 2.38B | 5.13% |
| Dec 31, 2025 | 2.27B | 21.86% |
| Dec 31, 2024 | 1.86B | -29.78% |
| Dec 29, 2023 | 2.65B | -14.93% |
| Dec 30, 2022 | 3.11B | -34.18% |
| Dec 31, 2021 | 4.73B | -28.02% |
| Apr 9, 2021 | 6.57B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novoprotein Scientific | 2.79B |
| Shanghai Serum Bio-Technology | 2.75B |
| Shandong Sito Bio-technology | 2.69B |
| Jilin Jian Yisheng Pharmaceutical | 2.67B |
| Shanghai Universal Biotech | 2.60B |
| Zhejiang East Asia Pharmaceutical | 2.38B |
| Guiyang Xintian Pharmaceutical | 2.36B |
| Jiangsu CoWin Biotech | 2.22B |